Table 1. Clinical features of 45 patients undergoing diagnostic biopsy – cohort two.
Variable | |
---|---|
| |
Age (mean ± S.E.) | 67.07 ± 1.7 |
| |
Sex (male/female) | 39/6 |
| |
BMI (mean ± S.E.) | 28.8 ± 1.2 |
| |
Type 2 Diabetes Y/N | 24/21 |
| |
Cirrhosis Y/N | 25/20 |
| |
Etiology | |
None | 18 |
ALD | 9 |
NAFLD | 7 |
HCV | 3 |
AIH | 2 |
Haemochromatosis | 3 |
Cryptogenic | 3 |
| |
Edmondson Grade 1/2/3 | 13/23/9 |
| |
Size (cm) (mean ± S.E.) | 6.3 ± 0.70 |
| |
Number (mean ± S.E.) | 2.47 ± 0.47 |
| |
PVT Y:N | 6/32 |
| |
Extra-hepatic disease Y:N | 6/39 |
| |
INR (mean ± S.E.) | 1.02 ± 0.02 |
| |
Albumin (g/l) (mean ± S.E.) | 37.7 ± 0.89 |
| |
Bilirubin (μmol/l) | 25.7 ± 10.50 |
| |
Ascites Y:N | 5/40 |
| |
Encephalopathy Y:N | 0/44 |
| |
Childs-Pugh A/B/C | 39/5/1 |
| |
BCLC A/B/C/D | 14/9/20/2 |
| |
Median survival (months) | 24.60 |
Continuous data are presented as mean ± standard error. ALD – alcoholic liver disease; NAFLD – nonalcoholic fatty liver disease; HCV – hepatitis C virus; HBV – hepatitis B virus; AIH – autoimmune hepatitis; BMI – Body Mass Index; PVT – portal vein thrombosis; INR – international normalised ratio; BCLC – Barcelona Clinic for Liver Cancer